Fact CheckerSign in

NCT07696039Completed

Real-world Effectiveness and Safety of Omnipod 5 in Adults With Type 1 Diabetes: a 12-month Observational Study.

Source: ClinicalTrials.gov · Last updated 10 Jul 2026

Brief summary (registry, in English)

This retrospective observational cohort study aims to evaluate the real-world effectiveness and safety of the Omnipod® 5 Automated Insulin Delivery System in adults with type 1 diabetes receiving routine clinical care at a tertiary diabetes center. Continuous glucose monitoring metrics and glycated hemoglobin values obtained before initiation of Omnipod 5 and approximately after six, twelve and eighteen months of use will be compared to assess changes in glycemic control.

Status (registry)
Completed
Study type
Observational
Enrollment
300 (actual)
First submitted
1 Jul 2026
Start date
7 Jan 2026
Primary completion date
30 Jun 2026
Lead sponsor
Papa Giovanni XXIII Hospital
NCT number
NCT07696039

What you commit to

  • Study type: Observational
  • Participants enrolled: 300
  • From 7 Jan 2026 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other conditions judged by investigators to preclude reliable evaluation

Other

  • Missing baseline CGM data
  • Missing follow-up CGM data
  • Discontinuation of Omnipod® 5 before outcome assessment

Who the study is looking for

  • Adults aged ≥18 years
  • Diagnosis of type 1 diabetes
  • Initiation of Omnipod® 5 during routine clinical care
  • Availability of baseline CGM data
  • Availability of at least six-month follow-up CGM data

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ASST Papa Giovanni XXIII Bergamo
Coordinator of this site? Confirm its status
BergamoItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.